CCD not purely an acedemic victory. COVID - 19 will be with us for years to come and therapeutic ABL will be needed for years to come as I understand it.
1) Apabetalone treatment reduces SARS-CoV-2 infectivity and completely prevents cardiac damage in a cytokine-storm model
2) Apabetalone Treatment Prevents COVID-19 Infection of Human Lung Cell
Koo